2093321-19-6,PSMA1007主要應(yīng)用在哪些方面?
一、試劑基團(tuán)反應(yīng)特點(diǎn):
螯合劑小分子抑制劑PSMA-1007(CAS號(hào):2093321-19-6),主要應(yīng)用在特異性膜抗原( PSMA) PET/CT 在檢測(cè)方面具有高靈敏度和特異度,可用于原發(fā)性prostatic cancer的定位與分期、復(fù)發(fā)性prostatic cancer的監(jiān)測(cè)。

二、基礎(chǔ)產(chǎn)品數(shù)據(jù):
CAS:2093321-19-6
中文名:Glu-Ureido型特異性膜抗原PSMA抑制劑
英文名:PSMA1007
試劑廠家:陜西新研博美生物科技有限公司
結(jié)構(gòu)式:

三、詳細(xì)產(chǎn)品數(shù)據(jù):
分子式:C49H55FN8O16
分子量:1031.0174
Purity standard:95%+,具體的試劑可以在線進(jìn)行咨詢
Storage conditions:At 20 ℃, in a cool, dry and well ventilated warehouse
Packaging specification:1g、5g、10g等(Customized packaging will be carried out according to the situation)
Solubility:Soluble in most organic solvents, such as DCM, DMF, DMSO, THF, etc., with good solubility in water)
In stock:SCommunicate with suppliers
Precautions:Keep a dry environment when using, and avoid frequent thawing for freezing.
四、試劑系列產(chǎn)品:
FAPI-08
FAPI-09
FAPI-10
FAPI-11
FAPI-12
FAPI-14
FAPI-15
FAPI-2

上述信息均由陜西新研博美生物科技有限公司的小編 XYBMWD所整理?
2093321-19-6,PSMA1007主要應(yīng)用在哪些方面?的評(píng)論 (共 條)
